Synchronization of preimplantation embryo development to blastocysts is one of the prerequisites for normal embryo implantation. While previous studies have ascribed an adverse effect to aberrant opioid signaling on embryo and fetal development, it has remained unclear whether the opioid system is operative in early pregnancy events. In the present study, employing multiple pharmacological and genetic approaches, we demonstrated that preimplantation embryos spanning the zygote to blastocyst express the opioid receptor subtypes and the oviduct expresses endogenous opioid precursors dynamically, which suggest that opioid signaling is functionally operative during preimplantation embryo development. Subsequent analysis further revealed that an aberrantly activated opioid signaling by morphine can remarkably derail normal preimplantation embryo development via inhibiting intracellular calcium mobilization, while a cotreatment of naloxone with morphine can remarkably reverse the adverse effects of morphine on preimplantation embryo development. Besides shedding light on the pathophysiological significance of the opioid system during early embryo development in mice, our findings have potential clinical relevance because an abused use of illicit opiate drugs is frequently associated with retarded fetal development and pregnancy failure in women.
INTRODUCTION
Preimplantation embryo development in mammals starts with the fertilization of an egg by a sperm. Once fertilized, the ovum, referred to as the zygote, undergoes mitotic division and cellular differentiation, leading to development of a multicellular embryo, passing through various embryonic stages, including 2-, 4-, and 8-cell embryos. In mice, the preimplantation embryo at late 8-cell stage undergoes compaction to form a morula and subsequently differentiates to a blastocyst by cavitation [1] . Increasing epidemiological studies support the concept that the quality of early embryos determines the pregnancy outcome [2] [3] [4] [5] . For example, more than 60% of fertilized eggs in humans are unable to survive to delivery, mainly due to early embryo developmental failure before and during implantation [6] . Therefore, it is extremely important to better understand the molecular basis governing preimplantation embryo development, which is essential for pregnancy success. In this respect, previous studies have ascribed various detrimental effects to opioid ligand-receptor signaling on early pregnancy events [7] [8] [9] [10] [11] . However, it has remained largely unexplored whether and how aberrant opioid signaling would derail normal preimplantation embryo development.
The opioid system is composed of three classic G-proteincoupled opioid receptors, the delta (d, Oprd/DOR), mu (l, Oprm/MOR), and kappa (j, Oprk/KOR) subtypes, and various endogenous ligands and exogenous receptor-binding compounds [12, 13] . The opioid receptors have been detected in a wide spectrum of central and peripheral tissues [14] [15] [16] [17] and have been shown to participate in opioid-induced analgesia, stress, tolerance, and endocrine, respiration, and immunological responses [18] . With respect to opioid ligands, endorphins, enkephalins, and dynorphins are endogenous opioids derived from distinct precursors such as pro-opiomelanocortin (POMC), preproenkephalin (PENK), and preprodynorphin (PDYN), respectively. The endogenous levels of these active opioid peptides are timely regulated by the synthetic prohormone convertase 1/3 (PC1/3) and prohormone convertase 2 (PC2) [19, 20] as well as the degrading enzyme, membrane metallo-endopeptidase (MME), also known as neutral endopeptidase (NEP) [21] [22] [23] . Moreover, morphine, one of the world's oldest known drugs, is an exogenous opioid, which has been widely used for the treatment of severe acute and chronic pain. However, addiction to morphine has been frequently observed in patients. Most importantly, an abused use of illicit opioids during pregnancy in women is associated with an increased risk of adverse outcomes. For example, opioids can adversely affect embryonic growth and neural development [7, 24, 25] . Moreover, opioid withdrawal has been associated with poor fetal growth, preterm delivery, and fetal death [26] [27] [28] [29] . However, the potential significance of the opioid system during early pregnancy events has remained largely unexplored.
In the present study, we demonstrate that opioid receptors are spatiotemporally expressed in preimplantation embryos and the endogenous levels of opioid peptides are timely coordinated with the oviductal expression of PC1/3 and Mme. Excessive morphine exposure adversely affects preimplantation embryo development via inhibiting Ca 2þ influx. These findings suggest that preimplantation embryos are potential targets for opioid signaling, further shedding light on the mechanism for adverse pregnancy outcome of illicit opioid drug use in women of childbearing age.
MATERIALS AND METHODS

Animals and Treatment
Mice were housed in the Institutional Animal Care Facility of the Institute of Zoology according to institutional guidelines for laboratory animals. The animal use protocol has been approved by the institutional Animal Care Committee of Institute of Zoology. CD-1 female mice (8-wk old) were purchased from the Vital River Laboratory Animal Technology Co., Ltd. Opioid receptor knockout mice (Oprm
, C57 background) were purchased from the Jackson Laboratory. The female mice were caged with the males of the same strain to induce pregnancy, and females with a vaginal plug the next morning (0800-0900 h) were considered as Day 1 of pregnancy (Day 1 ¼ vaginal plug). To examine the effect of morphine on preimplantation embryo development in vivo, pregnant mice received intraperitoneal injections of 50 mg/kg body weight morphine (Sinopharm Group Co., Ltd.) and/or 1 mg/ kg body weight naloxone (Tocris Cookson Ltd.) twice a day for 2 consecutive days (Days 2 and 3 of pregnancy, 0900 and 2100 h). Mice receiving sterile saline injections served as the control.
RT-PCR Analysis of Opioid System Components in Early Embryos and Oviduct
Preimplantation embryos at the 1-cell, 2-cell, 4-cell, 8-cell, morula, and blastocyst stages were collected by flushing the oviduct and uterus on Days 1-4 of pregnancy. About 100 embryos of each developmental stage were collected and pooled from several mice and stored in a small volume of TRIzol reagent (Invitrogen) at À808C before RNA extraction. The mouse oviducts were collected on Days 1-4 of pregnancy. Total RNA was isolated from preimplantation embryos and oviducts as previously described [30] . To examine opioid receptors mRNA expression in the preimplantation mouse embryo, reverse transcription-coupled PCR (RT-PCR) was employed, and the endogenous opioid peptide precursors Pomc, Penk, and Pdyn mRNA were detected by quantitative real-time PCR ([qRT-PCR] SYBR Green I analysis using the ABI 7500 sequence detector system according to the manufacturer's instructions). All the experiments were repeated at least three times. Primers for qRT-PCR or RT-PCR are listed in Supplemental Table S1 (all the Supplemental Data are available online at www.biolreprod.org).
Southern Blot Analysis
Southern blots with digoxygenin-labeled cRNA probes (Oprm, Oprd, Oprk, and b-actin) were performed as previously described [31] . Briefly, the amplified RT-PCR products were electrophoresed on agarose gels (1.5%), and then the agarose gels underwent denaturation, neutralization, transmembrane hybridization, and detection. Experimental and negative controls were run simultaneously.
Immunofluorescence
To localize MOR, DOR, and KOR in embryos at different stages of development as well as the expression of POMC in the oviduct, antibodies specific to MOR (Thermo), DOR-1 (Santa Cruz), KOR-1 (Santa Cruz), POMC (Abcam), and secondary antibodies conjugated with Cy2 or Cy3 dyes (Jackson ImmunoResearch Laboratories Inc.) were used. Rabbit or goat immunoglobulin G were used as the negative control in replacing the primary antibodies raised in the rabbit (MOR, 1:200; DOR-1, 1:200; KOR-1, 1:200) or the goat (POMC, 1:200). Immunofluorescence images were captured in a Zeiss LSM 710 confocal scanning laser microscope as described previously [30, 32] . Propidium iodide (Sigma) or SYTO-13 green dye was used for nuclear staining.
In Situ Hybridization
In situ hybridization with digoxygenin was performed as previously described [32] . Mouse-specific cRNA probes for Penk, Pdyn, Pc1/3, and Mme were used for hybridization. Cryosections hybridized with sense probes served as negative controls.
Culture of Preimplantation Embryos
To study the effects of morphine on preimplantation embryo development, 2-cell embryos were recovered on Day 2 (0900-1000 h) with Whitten medium containing 0.3% bovine serum albumin [31] and cultured in groups of 5-10 in 25 ll of medium under silicon oil in an atmosphere of 5% CO 2 /95% air at 378C for 72 h with morphine and/or naloxone. Embryos were observed every 12 h to monitor their development. At the termination of the culture, the number of embryos that formed blastocysts was recorded.
Calcium Mobilization and Imaging
Calcium mobilization and imaging were monitored as described previously [33] , Briefly, the zona pellucida of preimplantation embryos were removed with acidic Tyrode solution (T1788; Sigma), and then the embryos were incubated at 378C for 30 min in Whitten medium containing 1 lM of the cellpermeant acetoxymethyl ester form of fluo-4, 0.02% pluronic F127 (Molecular Probes), and 2.5 mM probenecid. Preloaded 2-cell embryos were washed and transferred into Tyrode solution containing 2.5 mM probenecid, and then incubated in the presence or absence of morphine (50 lM) and naloxone (1 lM). The stimulus for voltage-gated Ca 2þ channel activation in embryo was a rapid increase in KCl concentration from 6 to 60 mM in the bath solution. To chelate extracellular Ca 2þ , 1 mM 1, 2-bis (o-aminophenoxy) ethane-N, N, N 0 , N 0 -tetraacetate (BAPTA) was used in the bath solution instead of CaCl 2 . Images were acquired for 5 min after the addition of KCl on a Zeiss LSM 710 confocal scanning laser microscope.
Statistical Analysis
Statistical analysis was performed with the SPSS 20 program. The results for recording embryo developmental status were analyzed by using chi square analysis, and the qRT-PCR analysis and Ca 2þ pixel measurement were analyzed by using one-way analysis of variance (ANOVA). The data are shown as means 6 SEM. A P , 0.05 value was considered as significant difference between the compared values.
RESULTS
Dynamic Expressions of Opioid System Components in the Preimplantation Embryo and Oviduct During Early Pregnancy
To explore the pathological significance of opioid signaling in preimplantation embryo development during early pregnancy, we first examined the expression of opioid receptors in early embryos spanning the 1-cell zygote to the blastocyst by employing Sothern blot analysis and immunofluorescence staining. As illustrated in Figure 1 , A-D, and Supplemental Figure S1 , both mRNA and protein for MOR, DOR, and KOR receptors were expressed in preimplantation embryos spanning 1-cell to blastocyst stages. It is worth noting that while the Oprm mRNA showed a stable expression in the preimplantation embryos, the mRNA expression of Oprd and Oprk receptors exhibited a gradual decline in early embryos. The results indicated that preimplantation embryos were a potential target for endogenous opioid signaling.
To verify this, we next explored the spatiotemporal expression profile of opioid precursors as well as the respective synthetic and degrading enzymes PC1/3 and Mme in the oviduct, where the preimplantation embryo development occurs. Quantitative RT-PCR analysis revealed that Pomc, Penk, and Pdyn mRNAs were highly expressed in the oviduct on Days 1-4 of pregnancy ( Fig. 2A) . Interestingly, while Pomc was significantly upregulated on Day 2 and decreased thereafter, Penk showed a relative higher expression on Days 2-3, and Pdyn peaked on Day 3 of pregnancy ( Fig. 2A) . Immunofluorescence analysis further demonstrated that POMC was mainly expressed in both the oviductal ampulla and isthmus epithelium on Days 1-4 of pregnancy (Fig. 2B) . In contrast, Penk and Pdyn were primarily expressed in the isthmus epithelium, but not in the ampulla region by the in situ CHEN ET AL. hybridization analysis (Fig. 2C) . Interestingly, while the opioid peptide synthetic enzyme Pc1/3 was expressed at lower level in the isthmus epithelium, the degrading enzyme Mme (NEP) showed an increased expression in the isthmus epithelium on Days 2-4 (Fig. 2D) . This spatiotemporal expression of the gate-keeping enzymes for opioid peptides in the oviduct suggested a tightly regulated opioid signaling during preimplantation development. Thus, we surmised that an aberrant opioid signaling would derail the normal early pregnancy events.
Morphine Derails Preimplantation Embryo Development via Opioid l Receptor
To test our hypothesis that an exaggerated opioid signaling would adversely affect preimplantation embryo development, we applied a pharmacological approach using morphine to challenge the pregnant mice. Females receiving morphine on Days 2-3 exhibited a retarded early embryo development when analyzed on Day 4 of pregnancy. For example, while more than 90% embryos formed blastocysts in saline-treated mice, only about 50% of embryos developed into blastocyst in morphinechallenged females (Table 1 ). This adverse effect of morphine on embryo development can be discerned as early as 12 h postmorphine treatment when analyzed on Day 2.5 ( Table 2 , Supplemental Fig. S2 ). For example, while most of the salinetreated embryos developed into the 4-cell stage, in the morphine-treated group, many embryos were still arrested at the 2-or 3-cell stage (Supplemental Fig. S2A ). Immunofluorescence analysis of phospho-Histone 3 (pH3), the mitosis maker, further revealed that the undivided cells treated by morphine were arrest at the M-phase (Supplemental Fig. S2B ). However, a combined treatment of morphine with the general opioid receptor antagonist naloxone largely restored normal preimplantation embryo development (Table 1) . Moreover, a similar inhibitory effect of morphine on blastocyst formation was observed when 2-cell embryos were treated with morphine in culture, and this adverse effect can also be reversed by cotreatment with naloxone (Fig. 3, A and B) . These findings collectively indicated that preimplantation embryo was a direct target for the opioid system.
Because the l receptor is the major receptor subtype mediating morphine bioactivities [34, 35] , we employed the l opioid receptor (Oprm À/À ) mutant mice to ascertain the underlying functional receptor subtype during preimplantation embryo development. As illustrated in Table 3 , while morphine can significantly inhibit preimplantation development of embryos into blastocysts in wild-type females, this adverse effect was completely abolished in mice genetically lacking the l receptor. This observation reinforces the hypothesis that OPRM is at least one of the functional receptor subtypes for opioid signaling in the preimplantation embryos in mice.
Morphine Inhibits Depolarization-Induced Ca 2þ Influx in Preimplantation Embryos
Because previous studies have demonstrated that opioid receptors are negatively coupled to voltage-gated Ca 2þ channels [36] [37] [38] , we next investigated whether morphine would influence Ca 2þ mobilization, thus interfering with the normal duration of preimplantation embryo development. A rapid increased concentration of KCl could induce membrane depolarization that elevates the intracellular Ca 2þ mobilization, and this method has been widely used to study the properties of Ca 2þ channel-mediated signal transduction in various cell types [39] . As shown in Figure 4A , we observed that exposure of 2-cell embryos to increased concentrations of KCl from 6 to 60 mM could rapidly activate Ca 2þ influx into the cytoplasm with a peak at 30 sec. This KCl-induced Ca 2þ mobilization was greatly abolished by chelating extracellular Ca 2þ with BAPTA, suggesting that voltage-gated Ca 2þ channels are involved in this dynamic Ca 2þ influx in preimplantation embryos. We further observed that a pretreatment with 50 lM morphine dramatically inhibited the KCl-induced Ca 2þ influx (Fig. 4B) . A similar attenuated Ca 2þ mobilization was observed when 4-and 8-cell embryos were exposed to morphine (Supplemental Fig. S3 ). Moreover, this inhibition by 50 lM morphine was specifically reversed by the opioid receptor antagonist naloxone (Fig. 4B) . This is consistent with previous observations that Ca 2þ signaling is crucial for blastocyst formation and function [33, 40, 41] . Nonetheless, our findings revealed that an aberrant opioid signaling derailed normal preimplantation embryo development via disrupting Ca 2þ mobilization.
DISCUSSION
Preimplantation development of the embryo to form a functionally normal blastocyst is a prerequisite for implantation in mammals. In the present study, we provided multiple lines of evidence that the preimplantation embryo is a target of endogenous opioid signaling in mice. We found that an aberrantly activated opioid signal via the OPRM receptors can remarkably inhibit intracellular Ca 2þ mobilization and thus a Mice who failed to recover embryos were excluded from further analysis. ** P , 0.01.
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expressed in the oviduct epithelium at the isthmus region, but not the ampulla region. D) Spatiotemporal expression profiles Pc1/3 and Mme in the oviduct. The results show that the opioid peptide synthetic enzyme Pc1/3 was expressed at lower levels in the isthmus epithelium, while the degrading enzyme Mme showed an increased expression in the isthmus epithelium on Days 2-4. Experiments were repeated three times (*P , 0.05). Data are shown as means 6 SEM, Images shown Cy3-labeled POMC in red, SYTO-13-labeled nuclei in green. Immunofluorescence was captured by Zeiss LSM710 confocal scanning laser microscope. Sense probes were used as negative controls in B-D. Bars ¼ 20 lm. 
MOUSE EMBRYO IS A TARGET FOR OPIOID SIGNALING
significantly slow the duration of preimplantation embryo development and blastocyst formation. Previous studies have shown that opioid signaling is a potential player in regulating various pregnancy events [42] [43] [44] . For example, the expression of opioid receptors is broadly detected in the reproductive system, including the sperm and placenta [45, 46] . Our current findings demonstrate that the opioid receptor subtypes are dynamically expressed in the preimplantation embryos, which suggests that opioid signaling is functionally operative during preimplantation embryo development. Notably, we found that the immunofluorescence staining of opioid receptors are not only in cell membrane as expected, but are also positive in the cytoplasm. This unusual expression pattern supports the hypothesis that opioid receptors could be internalized after specific signaling stimulation during preimplantation embryo development. In fact, a similar expression pattern of opioid receptors has also been reported in the neuron and other systems [47] [48] [49] [50] . The efficacy of the endogenous opioid system is regulated at multiple levels, including the status of the opioid receptors as well as the levels of endogenous opioid ligands. In the present study, our results show that the synthetic and degrading enzymes of the opioid peptide were differentially expressed in the oviduct in a stageand region-specific contrasting profile, suggesting that the coordinated opioid synthesis and degradation activity creates appropriate signaling conducive to normal preimplantation embryo development. Indeed, an aberrantly enhanced opioid signaling via morphine exposure during early pregnancy induced an asynchronous development of preimplantation prior to implantation. This arrested development of preimplantation embryo after exposure to morphine is consistent with previous findings of retarded fetal development and pregnancy failure after early pregnancy maternal opioid analgesic exposure [9, [42] [43] [44] . Employing an Oprm-deficient mouse model, we further demonstrated that OPRM is the major functional receptor mediating the adverse effects of aberrant opioid signaling during early pregnancy.
Observations of retarded early embryo development in response to a morphine challenge is in line with previous finding that an aberrant cannabinoid signaling interferes with preimplantation embryo development [31, 51] . For example, previous studies have demonstrated that cannabinoid signaling plays a role in sperm-egg fertilization, preimplantation development of embryos and their timely transport from the oviduct into the uterus, and embryo-uterine cross-talk during implantation and decidualization [52] [53] [54] [55] [56] . Opioid receptors and cannabinoid receptors all belong to the G-protein-coupled receptors superfamilies. Increasing evidence demonstrate that opioid receptors and cannabinoid receptors show coexpression in many tissues and can mediate overlapping pharmacological responses in drug abuse and pain management [57] [58] [59] [60] . Moreover, the endogenous opioid system is significantly influenced by maternal or perinatal cannabinoid exposure [61] . However, it remains to determine whether there is any coordination between the endogenous cannabinoid and opioid systems in directing normal early embryogenesis.
During the course of searching for the answer of how morphine adversely affects preimplantation embryo development, we observed that an aberrantly elevated opioid signal can largely inhibit intracellular Ca 2þ mobilization, thus derailing normal early embryo development. Previous studies have shown that the elevation of the intracellular Ca 2þ signal is important for egg activation and the early development [33, 40, 41, [62] [63] [64] [65] [66] [67] . Calcitonin acting through calcitonin receptors, which is expressed in mouse preimplantation embryos, rapidly elevates cytosolic free Ca 2þ levels in embryos at the 4-cell to blastocyst stages [68] . Therefore, it is conceivable that retarded embryo development is mainly due to restrained Ca 2þ channel activities. Previous studies have reported that several voltagegated Ca 2þ channels are present in preimplantation embryo, such as the L-, T-, and N-type channels [39, 69, 70] . It would be interesting to further explore in a future study which types of Ca 2þ channels may be sensitive to morphine's inhibitory effects in conjunction with differential opioid receptor subtypes during preimplantation embryo development. Nonetheless, we demonstrated herein that preimplantation embryo is a target of opioid signaling. Our findings have strong clinical relevance because illicit opium use by women of childbearing age result in increased risk of pregnancy complications [71, 72] . 
